IFLR1000

UPL $4.2 billion acquisition of Arysta Lifescience

23/7/2018
Private acquisition
Select tab

$ 4.2 billion

Announced

23/7/2018

Overview:

  • UBS Investment Bank and Barclays acted as financial advisers to Platform Specialty Products Corporation.
  • Credit Suisse acted as financial adviser to Abu Dhabi Investment Authority and TPG Capital.

Daniel Semerdzhiev - Data analyst

Jurisdiction:

India

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

United States

Industry sector:

Agriculture

Firms:
Cleary Gottlieb Steen & Hamilton

Party: TPG Capital (Investor)

Party: Abu Dhabi Investment Authority (Investor)

Greenberg Traurig

Party: Platform Specialty Products Corporation (Seller)

Jones Day

Party: UPL Corporation Ltd (Acquirer)

Lawyers: Ben Witherall, Dennis Barsky, Sushma Jobanputra, Vinay Kurien

JSA

Party: UPL Corporation Ltd (Acquirer)

Lawyers: Aashit Shah, Bharati Joshi, Lalit Kumar, Utsav Johri

Sullivan & Cromwell

Party: UBS Investment Bank (Financial adviser)

Lawyer: Melissa Sawyer

Touchstone Partners

Party: TPG Capital (Investor)

Party: Abu Dhabi Investment Authority (Investor)

Related deals